Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 5/22/2026Bayer Wins China Approval for Kerendia (finerenone) in Heart Failure
  • 5/22/2026Qyuns Therapeutics Expands China Biologics Portfolio With Ustekinumab ...
  • 5/22/2026J&J Wins China Approval for Nipocalimab in Myasthenia Gravis
  • 5/22/2026Nuance Wins China IND Clearance for Actair Allergy Immunotherapy Trial
  • 5/22/2026China Clears First INDs for 25 Novel Drugs Last Week
  • 5/21/2026United Labs Wins China IND Clearance for Novel Broad-Spectrum β-Lacta...
  • 5/19/2026Merck's China-Licensed ADC Succeeds in First Global Phase 3 Trial
  • 5/19/2026China Advances Parrot Fever and Ebola Vaccine Programs
  • 5/19/2026CSPC Wins China Approval to Begin Clinical Trials for First-in-Class K...
  • 5/19/2026Akeso Reports Encouraging Phase II AML Data for Anti-CD47 Antibody Lig...
  • 5/19/2026Vincentage Posts Phase III Obesity Data as Oral GLP-1 Race in China He...
  • 5/18/2026Harbour BioMed Unveils Promising Preclinical Data for AI-Designed Obes...
  • 5/18/2026AbbVie's Epcoritamab Wins First China Approval for Relapsed or Refract...
  • 5/18/2026China Approves Salubris' Once-Weekly Teriparatide for Osteoporosis
  • 5/18/2026Haisco Pharma to Present Positive Phase III PNH Data for Factor B Inhi...
  • 5/15/2026BeOne's Sonrotoclax Wins FDA Accelerated Approval for Mantle Cell Lymp...
  • 5/14/2026Hansoh Advances EGFR Pipeline as HS-10541 Wins Clinical Trial Approval...
  • 5/13/2026Chinese Researchers Explore Mosquito-Delivered "Flying Vaccines" for B...
  • 5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...
  • 5/12/2026China Approves Novel EGFR, JAK2 Therapies as Wave of Innovative INDs A...
  • 5/12/2026DualityBio Reports Strong First-Line TNBC Data for DB-1305/BNT325 Plus...
  • 5/12/2026CytoCares Reports First-in-Human AACR Data for CD19/CD3/CD28 Trispecif...
  • 5/12/2026BeOne Culls Multiple Early Oncology Programs, Halts Phase 2 IRAK4 Degr...
  • 5/12/2026Sinocelltech Advances Dual Trispecific Antibody Combo Into Phase 1b/2 ...
  • 5/8/2026China Poised to Lead Next Wave of CAR-T Innovation in Solid Tumors, Sa...
  • 5/8/2026InnoCare Advances CDH17 ADC Into Clinic as Competition Builds in GI Ca...
  • 5/7/2026Cutia Wins China Approval for CU-30101 Topical Anesthetic Cream
  • 5/7/2026InnoCare Secures China IND Approval for Novel CDH17-Targeted ADC ICP-B...
  • 5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...
  • 5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)
  • Page:1/22 Total number of articles:651: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group